940 SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE HCV POLYMERASE INHIBITOR VCH-222 FOLLOWING SINGLE DOSE ADMINISTRATION IN HEALTHY VOLUNTEERS AND ANTIVIRAL ACTIVITY IN HCV-INFECTED INDIVIDUALS
Cooper, C, Larouche, R, Bourgault, B, Chauret, N, Proulx, L
Published in Journal of hepatology (2009)
Published in Journal of hepatology (2009)
Get full text
Journal Article
31 SAFETY AND ANTIVIRAL ACTIVITY OF THE HCV NON-NUCLEOSIDE POLYMERASE INHIBITOR VX-222 IN TREATMENT-NAIVE GENOTYPE 1 HCV-INFECTED PATIENTS
Rodriguez-Torres, M, Lawitz, E, Conway, B, Kaita, K, Sheikh, A.M, Ghalib, R, Adrover, R, Cooper, C, Silva, M, Rosario, M, Bourgault, B, Proulx, L, McHutchison, J.G
Published in Journal of hepatology (2010)
Published in Journal of hepatology (2010)
Get full text
Journal Article
854 RESULTS OF A SAFETY, TOLERABILITY AND PHARMACOKINETIC PHASE I STUDY OF VCH-916, A NOVEL POLYMERASE INHIBITOR FOR HCV, FOLLOWING SINGLE ASCENDING DOSES IN HEALTHY VOLUNTEERS
Proulx, L, Bourgault, B, Chauret, N, Larouche, R, Tanguay, M, Thibert, R
Published in Journal of hepatology (2008)
Published in Journal of hepatology (2008)
Get full text
Journal Article
92 SAFETY, TOLERABILITY AND ANTIVIRAL ACTIVITY OF VCH-916, A NOVEL NON-NUCLEOSIDE HCV POLYMERASE INHIBITOR IN PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION
Lawitz, E, Cooper, C, Rodriguez-Torres, M, Ghalib, R, Lalonde, R, Sheikh, A, Bourgault, B, Chauret, N, Proulx, L, McHutchison, J
Published in Journal of hepatology (2009)
Published in Journal of hepatology (2009)
Get full text
Journal Article